<DOC>
	<DOC>NCT03071965</DOC>
	<brief_summary>This study is a prospective, phase 2 extension study of participants previously enrolled in NTMT-01 and of participants enrolled in NTMT-02. This study is designed to evaluate long term safety and efficacy of the NT-501 implant in participants previously enrolled in the NTMT-01 and NTMT-02 protocols.</brief_summary>
	<brief_title>Extension Study of NT-501 Ciliary Neurotrophic Factor (CNTF) Implant for Macular Telangiectasia (MacTel)</brief_title>
	<detailed_description />
	<mesh_term>Telangiectasis</mesh_term>
	<criteria>Previously enrolled in the NTMT01 or NTMT02 protocol and received the NT501 implant and/or underwent a Sham procedure Participant must be offered sufficient opportunity to review and to understand the informed consent form, agree to the form's contents, and provide written informed consent. There are no Exclusion Criteria</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>